Evidence map›Paper›PMID 40454635›Full record

ArticleAddiction biology2025

Alcoholic Hepatitis in a Japanese Hospital: Losing Contact With Some Patients After Delirium Tremens May Lead to Missed Critical Events.

Hisanori Muto, Teiji Kuzuya, Yoshihiko Tachi, Yoshiaki Katano, Naoki Ohmiya, Takashi Kobayashi, Satoshi Yamamoto, Naoto Kawabe, Hijiri Sugiyama, Seiya Hagihara and 4 more

Abstract read
In one paragraph

Article in Addiction biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hisanori MutoDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.ORCID 0000-0003-2121-2494
Teiji KuzuyaDepartment of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
Yoshihiko TachiDepartment of Gastroenterology and Hepatology, Fujita Health University Okazaki Medical Center, Okazaki, Japan.
Yoshiaki KatanoDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
Naoki OhmiyaDepartment of Advanced Endoscopy, Fujita Health University, Toyoake, Japan.ORCID 0000-0002-7651-402X
Takashi KobayashiDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
Satoshi YamamotoDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.ORCID 0000-0001-8866-3690
Naoto KawabeDepartment of Gastroenterology and Hepatology, Fujita Health University, Toyoake, Japan.
Hijiri SugiyamaDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
Seiya HagiharaDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
Misae MatsushitaDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
Yutaro KajinoDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
Yosuke NaganoDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.
Senju HashimotoDepartment of Gastroenterology and Hepatology, Fujita Health University Bantane Hospital, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Japan, the establishment of diagnostic criteria for acute-on-chronic liver failure (ACLF) in 2022 has increased the focus on alcoholic hepatitis. Most hospitals in Japan lack specialized treatment units or psychiatrists for managing alcohol use disorders, leaving hepatologists to handle various aspects of the disease-a challenging task. This study retrospectively investigated the outcomes of alcoholic hepatitis in a typical Japanese hospital setting, stratified by ACLF diagnosis and other features, with the aim of identifying areas for possible improvement. We conducted a retrospective analysis of 88 patients hospitalized with alcoholic hepatitis, reviewing records for the diagnosis of ACLF or related conditions, development of delirium tremens (DT), risk factors, and patient outcomes. Patients meeting the Japanese criteria for ACLF or related conditions had significantly worse survival outcomes. DT developed in 13 patients, with low platelet counts and elevated γ-glutamyl transpeptidase levels identified as risk factors. Prophylactic oral benzodiazepines were found safe and significantly associated with preventing DT. Onset of DT during hospitalization did not measurably impact survival prognosis, but DT patients showed a tendency to break contact with our hospital and critical events may have been missed. While under hepatologist care, patients typically maintained sobriety, but relapse into alcohol-related health problems frequently occurred after follow-up was discontinued. In Japan, hepatologists may be missing important events with alcoholic hepatitis after follow-up discontinuation, especially in patients with DT. Therefore, integrated and collaborative care, particularly a psychosocial approach providing behavioural support, may reduce risk of relapse and improve patient prognosis.

trial registrationAll study protocols were reviewed and approved by the ethics committee at Fujita Health University School of Medicine (approval no. HM23-213).

Indexed as

Acute-On-Chronic Liver FailureAlcohol Withdrawal DeliriumHepatitis, AlcoholicAdultAgedBenzodiazepinesEast Asian PeopleFemaleHospitalizationHumansJapanMaleMiddle AgedRetrospective StudiesRisk FactorsBenzodiazepinesacute‐on‐chronic liver failurealcoholic hepatitisalcohol withdrawal syndromebenzodiazepinedelirium tremens

Identifiers

PMID40454635
PMCPMC12127994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.